Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.

A total of 95 schizophrenic or manic patients received zuclopenthixol (cis(Z)-clopenthixol) either intramuscularly or orally during a period of 2 to 4 weeks in mean daily doses of 25 mg (i.m.) or 75 mg (p.

[New proposals for the development of the concepts of neurotic anxiety, major depression and panic attack].

An accumulation of research results, laboratory and clinic, leads to revise the classification of disorders of anxious nature (anxiety disorders according to the DSM-III). An empirical confirmation allows to separate anxious states from panic attack and phobic behavior constituting a component separated from generalized anxiety, exaggerated emotional reactions to stress agents and obsessive-compulsive disorders. The response to pharmacotherapeutic agents and the important number of anxiety depression and mixed depression tends to make permeable the separating line between the nosological entities anxiety and depression.

[Integration of behaviorism in the technics and methods of psychologic action].

Behaviourism is described as the study, the analysis and modifications of behaviours interacting with the milieu: a unit of methods and applications is noted and a theoretical body of behaviour changes is emphasized. In the clinic, the objective attitude and statement that psychopathology is the science of abnormal behaviours and not the science of mental states, contrast behaviourism with other methods such as psychoanalysis. In therapy and revalidation, behaviourism is one of the individual or group psychological reeducation method.